FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016048690> ?p ?o ?g. }

• W3016048690 endingPage "876.e12" @default.
• W3016048690 startingPage "865" @default.
• W3016048690 abstract "The coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, has highlighted the need for antiviral approaches that can target emerging viruses with no effective vaccines or pharmaceuticals. Here, we demonstrate a CRISPR-Cas13-based strategy, PAC-MAN (prophylactic antiviral CRISPR in human cells), for viral inhibition that can effectively degrade RNA from SARS-CoV-2 sequences and live influenza A virus (IAV) in human lung epithelial cells. We designed and screened CRISPR RNAs (crRNAs) targeting conserved viral regions and identified functional crRNAs targeting SARS-CoV-2. This approach effectively reduced H1N1 IAV load in respiratory epithelial cells. Our bioinformatic analysis showed that a group of only six crRNAs can target more than 90% of all coronaviruses. With the development of a safe and effective system for respiratory tract delivery, PAC-MAN has the potential to become an important pan-coronavirus inhibition strategy." @default.
• W3016048690 created "2020-04-17" @default.
• W3016048690 creator A5009068819 @default.
• W3016048690 creator A5014773730 @default.
• W3016048690 creator A5017305667 @default.
• W3016048690 creator A5023993045 @default.
• W3016048690 creator A5027876177 @default.
• W3016048690 creator A5031397502 @default.
• W3016048690 creator A5047829117 @default.
• W3016048690 creator A5051510467 @default.
• W3016048690 creator A5058519180 @default.
• W3016048690 creator A5059109729 @default.
• W3016048690 creator A5062512473 @default.
• W3016048690 creator A5062650399 @default.
• W3016048690 creator A5064828779 @default.
• W3016048690 creator A5065271113 @default.
• W3016048690 creator A5086741929 @default.
• W3016048690 date "2020-05-01" @default.
• W3016048690 modified "2023-10-12" @default.
• W3016048690 title "Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza" @default.
• W3016048690 cites W1970078053 @default.
• W3016048690 cites W1985336857 @default.
• W3016048690 cites W2005059928 @default.
• W3016048690 cites W2012505332 @default.
• W3016048690 cites W2022889543 @default.
• W3016048690 cites W2028338024 @default.
• W3016048690 cites W2044343035 @default.
• W3016048690 cites W2068638086 @default.
• W3016048690 cites W2071657440 @default.
• W3016048690 cites W2076922024 @default.
• W3016048690 cites W2094875270 @default.
• W3016048690 cites W2103503670 @default.
• W3016048690 cites W2105418530 @default.
• W3016048690 cites W2118504844 @default.
• W3016048690 cites W2124985265 @default.
• W3016048690 cites W2129179244 @default.
• W3016048690 cites W2158073495 @default.
• W3016048690 cites W2160378127 @default.
• W3016048690 cites W2160488806 @default.
• W3016048690 cites W2209402024 @default.
• W3016048690 cites W2411425451 @default.
• W3016048690 cites W2474039476 @default.
• W3016048690 cites W2567995016 @default.
• W3016048690 cites W2570278065 @default.
• W3016048690 cites W2621872572 @default.
• W3016048690 cites W2750186728 @default.
• W3016048690 cites W2785904295 @default.
• W3016048690 cites W2793175780 @default.
• W3016048690 cites W2793349369 @default.
• W3016048690 cites W2793359586 @default.
• W3016048690 cites W2889291148 @default.
• W3016048690 cites W2893976143 @default.
• W3016048690 cites W2914037739 @default.
• W3016048690 cites W2914518223 @default.
• W3016048690 cites W2927961455 @default.
• W3016048690 cites W2971493710 @default.
• W3016048690 cites W2978341767 @default.
• W3016048690 cites W2979487934 @default.
• W3016048690 cites W2982062700 @default.
• W3016048690 cites W2990436921 @default.
• W3016048690 cites W2991574074 @default.
• W3016048690 cites W2999105079 @default.
• W3016048690 cites W3003217347 @default.
• W3016048690 cites W3003464757 @default.
• W3016048690 cites W3005949806 @default.
• W3016048690 cites W3010020071 @default.
• W3016048690 cites W3010200166 @default.
• W3016048690 cites W3011119456 @default.
• W3016048690 cites W4210997720 @default.
• W3016048690 doi "https://doi.org/10.1016/j.cell.2020.04.020" @default.
• W3016048690 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7189862" @default.
• W3016048690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32353252" @default.
• W3016048690 hasPublicationYear "2020" @default.
• W3016048690 type Work @default.
• W3016048690 sameAs 3016048690 @default.
• W3016048690 citedByCount "324" @default.
• W3016048690 countsByYear W30160486902020 @default.
• W3016048690 countsByYear W30160486902021 @default.
• W3016048690 countsByYear W30160486902022 @default.
• W3016048690 countsByYear W30160486902023 @default.
• W3016048690 crossrefType "journal-article" @default.
• W3016048690 hasAuthorship W3016048690A5009068819 @default.
• W3016048690 hasAuthorship W3016048690A5014773730 @default.
• W3016048690 hasAuthorship W3016048690A5017305667 @default.
• W3016048690 hasAuthorship W3016048690A5023993045 @default.
• W3016048690 hasAuthorship W3016048690A5027876177 @default.
• W3016048690 hasAuthorship W3016048690A5031397502 @default.
• W3016048690 hasAuthorship W3016048690A5047829117 @default.
• W3016048690 hasAuthorship W3016048690A5051510467 @default.
• W3016048690 hasAuthorship W3016048690A5058519180 @default.
• W3016048690 hasAuthorship W3016048690A5059109729 @default.
• W3016048690 hasAuthorship W3016048690A5062512473 @default.
• W3016048690 hasAuthorship W3016048690A5062650399 @default.
• W3016048690 hasAuthorship W3016048690A5064828779 @default.
• W3016048690 hasAuthorship W3016048690A5065271113 @default.
• W3016048690 hasAuthorship W3016048690A5086741929 @default.
• W3016048690 hasBestOaLocation W30160486901 @default.
• W3016048690 hasConcept C104317684 @default.

• next